GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Turmeric Acquisition Corp (NAS:TMPMU) » Definitions » Debt-to-Asset

Turmeric Acquisition (Turmeric Acquisition) Debt-to-Asset : 0.00 (As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Turmeric Acquisition Debt-to-Asset?

Turmeric Acquisition's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $0.00 Mil. Turmeric Acquisition's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $0.00 Mil. Turmeric Acquisition's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2022 was $97.91 Mil. Turmeric Acquisition's debt to asset for the quarter that ended in Jun. 2022 was 0.00.


Turmeric Acquisition Debt-to-Asset Historical Data

The historical data trend for Turmeric Acquisition's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turmeric Acquisition Debt-to-Asset Chart

Turmeric Acquisition Annual Data
Trend Dec20 Dec21
Debt-to-Asset
- -

Turmeric Acquisition Quarterly Data
Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Debt-to-Asset Get a 7-Day Free Trial - - - - -

Competitive Comparison of Turmeric Acquisition's Debt-to-Asset

For the Shell Companies subindustry, Turmeric Acquisition's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Turmeric Acquisition's Debt-to-Asset Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Turmeric Acquisition's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Turmeric Acquisition's Debt-to-Asset falls into.



Turmeric Acquisition Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Turmeric Acquisition's Debt-to-Asset for the fiscal year that ended in Dec. 2021 is calculated as

Turmeric Acquisition's Debt-to-Asset for the quarter that ended in Jun. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Turmeric Acquisition  (NAS:TMPMU) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Turmeric Acquisition Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Turmeric Acquisition's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Turmeric Acquisition (Turmeric Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
450 Kendall Street, Cambridge, MA, USA, 02142
Turmeric Acquisition Corp is a blank check company.
Executives
Luke Evnin officer: Chief Executive Officer THE JOHN HANCOCK TOWER, 200 CLARENDON STREET, 54TH STREET, BOSTON MA 02116
Mitchell H. Finer director C/O BLUEBIRD BIO, INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139
Edward Hurwitz officer: Chief Financial Officer
Todd Foley officer: President THE JOHN HANCOCK TOWER, 200 CLARENDON STREET 54TH FLOOR, BOSTON MA 02116
Pablo J Cagnoni director ONYX PHARMACEUTICALS, INC., 249 E. GRAND AVE., SOUTH SAN FRANCISCO CA 94080
David P Meeker director C/O PENWEST PHARMACEUTICALS CO, 39 OLD RIDGEBURY ROAD SUITE 11, DANBURY CT 06810
Andrew R Robbins director C/O 3200 WALNUT ST, BOULDER CO 80301
Matthew Roden director 450 KENDALL STREET, CAMBRIDGE MA 02142
Turmeric Management, Llc 10 percent owner 450 KENDALL STREET, CAMBRIDGE MA 02142
Vinay Bhaskar officer: Chief Operating Officer 2000 SIERRA POINT PARKWAY, SUITE 701, BRISBANE CA 94005